AETERNUM HEALTH, INC. (AETN)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 80K 160K 240K Q1 '18: 0 Q2 '18: 0 Q3 '18: 0 Q4 '18: 0 Q1 '23: 22.3K Q2 '23: 31.1K Q3 '23: 27.1K Q4 '24: 65K Q1 '25: 225.8K Q2 '25: 199.6K Q3 '25: 192.5K Q4 '25: 203.7K Q1 '26: 41.3K Q1 '18 Q3 '18 Q1 '23 Q3 '23 Q1 '25 Q3 '25 Q1 '26

Gross Profit TTM

-50K 0 50K 100K 150K Q1 '23: -23.2K Q2 '23: -16.2K Q3 '23: -19K Q4 '24: -12.7K Q1 '25: 121.5K Q2 '25: 83.3K Q3 '25: 89.6K Q4 '25: 120.1K Q1 '26: -17.3K Q1 '23 Q3 '23 Q1 '25 Q3 '25 Q1 '26

Operating Income TTM

-750K -500K -250K 0 250K 500K 750K Q3 '15: -84.5K Q4 '15: -77.7K Q1 '16: -81.4K Q2 '16: -97.4K Q3 '16: -78.1K Q4 '16: -75.7K Q1 '17: -59.9K Q2 '17: -43.3K Q3 '17: -37.6K Q4 '17: -45.3K Q1 '18: -49K Q2 '18: -61.2K Q3 '18: -69.6K Q4 '18: -65.4K Q1 '19: -60.4K Q2 '19: -49.1K Q3 '19: -42K Q4 '19: -32.9K Q1 '20: -41.4K Q2 '20: -40.6K Q3 '20: -33.9K Q4 '20: -30.5K Q1 '21: -26.5K Q2 '21: -105.5K Q3 '21: -181.7K Q4 '21: -264.7K Q1 '22: -304K Q2 '22: -274.2K Q3 '22: -246.5K Q4 '22: -219.2K Q1 '23: -258.5K Q2 '23: -302K Q3 '23: -531.3K Q4 '24: -430.5K Q1 '25: -302.4K Q2 '25: -298.5K Q3 '25: -309.3K Q4 '25: -269.3K Q1 '26: -411.6K Q2 '26: -593.7K Q3 '16 Q4 '17 Q1 '19 Q2 '20 Q3 '21 Q4 '22 Q1 '25 Q2 '26

Net Income TTM

-2.4M -1.6M -800K 0 800K 1.6M 2.4M Q3 '13: -146.7K Q4 '13: -121.2K Q1 '14: -98.9K Q2 '14: -88K Q3 '14: 112.2K Q4 '14: 109.9K Q1 '16: -83.2K Q2 '16: -99.2K Q3 '16: -69.9K Q4 '16: -67.5K Q1 '17: -61.1K Q2 '17: -44.6K Q3 '17: -38.7K Q4 '17: -46.3K Q1 '18: -52.5K Q2 '18: -64.6K Q3 '18: -72.9K Q4 '18: -69K Q1 '19: -61.1K Q2 '19: -49.7K Q1 '20: -41.4K Q2 '20: -40.6K Q3 '20: -33.9K Q4 '20: -30.5K Q1 '21: -26.5K Q2 '21: -38.8K Q3 '21: -240.4K Q4 '21: -323.5K Q1 '22: -2.1M Q2 '22: -2.2M Q3 '22: -2M Q4 '22: -2M Q1 '23: -315.5K Q4 '24: -450.3K Q1 '25: -326.9K Q2 '25: -316.5K Q3 '25: -377.1K Q4 '25: -337.1K Q1 '26: -482.6K Q2 '26: 1.3M Q3 '14 Q4 '16 Q1 '18 Q2 '19 Q1 '21 Q2 '22 Q1 '25 Q2 '26

Cost of Revenue TTM

0 15K 30K 45K Q1 '23: 43.6K Q2 '23: 43.8K Q3 '23: 41.5K Q1 '23 Q2 '23 Q3 '23

Operating Cash Flow TTM

-1.8M -1.2M -600K 0 600K 1.2M 1.8M Q4 '15: -44K Q1 '16: -46K Q2 '16: -51.6K Q3 '16: -47.8K Q4 '16: -48.2K Q1 '17: -41.1K Q2 '17: -26.2K Q3 '17: -20.2K Q4 '17: -36.1K Q1 '18: -38K Q2 '18: -45K Q3 '18: -62.7K Q4 '18: -42.7K Q1 '19: -40.3K Q2 '19: -36.3K Q3 '19: -27.7K Q4 '19: -23.9K Q1 '20: -24.2K Q2 '20: -18.1K Q3 '20: -5.2K Q4 '20: -4.2K Q1 '21: -1.2K Q2 '21: -53.4K Q3 '21: -83.1K Q4 '21: -105.8K Q1 '22: -118K Q2 '22: -163.1K Q3 '22: -159.6K Q4 '22: -166.6K Q1 '23: -303.3K Q2 '23: -327.9K Q3 '23: -216.1K Q4 '23: -271.5K Q4 '24: -154K Q1 '25: -72K Q2 '25: -9.1K Q3 '25: 34.5K Q4 '25: -3K Q1 '26: -40.8K Q2 '26: -1.6M Q4 '16 Q1 '18 Q2 '19 Q3 '20 Q4 '21 Q1 '23 Q1 '25 Q2 '26

Free Cash Flow TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Shares Outstanding Quarterly

0 20M 40M 60M Q3 '13: 3.5M Q4 '13: 3.5M Q2 '14: 3.5M Q3 '14: 4.6M Q4 '14: 3.5M Q2 '15: 3.5M Q3 '15: 3.5M Q4 '15: 3.5M Q2 '16: 3.5M Q3 '16: 3.5M Q4 '16: 3.5M Q2 '17: 3.5M Q3 '17: 3.5M Q4 '17: 3.5M Q2 '18: 3.5M Q3 '18: 3.5M Q4 '18: 3.5M Q2 '19: 3.5M Q3 '19: 3.5M Q4 '19: 3.5M Q3 '20: 3.6M Q4 '20: 3.6M Q2 '21: 6.6M Q3 '21: 5.2M Q4 '21: 7.1M Q2 '22: 8.8M Q3 '22: 8.8M Q4 '22: 9.4M Q2 '23: 47.4M Q3 '23: 48.2M Q3 '23: 47.8M Q4 '23: 48.5M Q1 '24: 42.5M Q2 '24: 48.5M Q3 '24: 48.5M Q1 '25: 48.6M Q2 '25: 49.2M Q3 '25: 49.2M Q1 '26: 50.3M Q2 '26: 54.7M Q4 '14 Q3 '16 Q2 '18 Q4 '19 Q4 '21 Q3 '23 Q3 '24 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.45 -0.30 -0.15 0.00 0.15 0.30 0.45 Q1 '12: -0.07 Q2 '12: -0.11 Q3 '12: -0.08 Q4 '12: -0.07 Q1 '13: -0.06 Q2 '13: -0.04 Q3 '13: -0.04 Q4 '13: -0.04 Q1 '14: -0.04 Q2 '14: -0.03 Q3 '14: 0.01 Q4 '14: 0.01 Q1 '16: -0.02 Q2 '16: -0.03 Q3 '16: -0.02 Q4 '16: -0.01 Q1 '17: -0.01 Q2 '17: 0.00 Q3 '17: 0.00 Q4 '17: -0.01 Q1 '18: -0.01 Q2 '18: -0.01 Q3 '18: -0.02 Q4 '18: -0.02 Q4 '20: 0.00 Q1 '21: 0.00 Q2 '21: 0.00 Q3 '21: -0.04 Q4 '21: -0.05 Q1 '22: -0.35 Q2 '22: -0.35 Q3 '22: -0.30 Q4 '22: -0.30 Q3 '24: 0.00 Q4 '24: -0.01 Q1 '26: -0.01 Q2 '26: 0.02 Q2 '12 Q3 '13 Q4 '14 Q1 '17 Q2 '18 Q2 '21 Q3 '22 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.